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Each year in the United States, several thousand children are born suffering from
the consequences of congenital infection with human cytomegalovirus (HCMV)'
(1). Apart from fatal cases, the most severe outcomeofintrauterine infection is damage
to the central nervous system, resulting in psychomotor retardation and neuromus-
cular disorder, hearing loss, chorioretinitis, or optic atrophy. The mechanism by
which HCMV causes these effects is unknown. One possibility is that cytolytic in-
fection ofcertain critical cells in the embryo or fetus by HCMV leads to the ob-
served abnormalities. On the other hand, HCMV can infect cells without cytolysis
and so may act indirectly toeffect fetal damage, forexample, by altering theexpres-
sion ofcellular genes. To investigate how HCMV might affect thedeveloping human
embryo, we have studied the replication ofthis virus, and its effects on the expres-
sion ofembryonic cell surface antigens, incultures ofhuman embryonal carcinoma
(EC) cells and human diploid fibroblasts.
EC cells, the stem cells ofteratocarcinomas, resembleearlyembyronic stem cells,
and their differentiation in vitro provides a model ofembryonic cellular differentia-
tion (2). The TERA-2-derived human EC cell line, NTERA-2 cl.Dl (NT2/Dl) (3,
4), is not permissivefor HCMVreplicationuntilinducedto differentiate with retinoic
acid (RA) (5-9), when shifts in glycolipid synthesis accompany the appearance of
distinct subsets ofcells marked by differential expression of specific glycolipid an-
tigens 10). Wehave suggested that theobservedchanges inglycolipid synthesis result
from regulation ofkey glycosyl transferases that control the synthesis of different
oligosaccharide core structures (11). Such switching ofcell surface glycolipids may
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provide important cues for regulating specific cell interactions during embryonic
development. We now report that infection ofpermissive differentiated NT2/Dl cells
and diploid human fibroblasts with HCMV induces expression of the lactoseries
glycolipid, stage-specific embryonic antigen 1 (SSEA-1), and we hypothesize that this
induced expression of SSEA-1 may have relevance for the mechanism of HCMV
pathogenesis in the developing fetus.
Materials and Methods
Cells.
￿
NTERA-2 c1.D1 (abbreviated NT2/Dl) is a cloned EC subline of the human ter-
atocarcinoma cell line TERA-2 (3). These cells were maintained with an EC phenotype by
culturing at high cell density as previously described. Differentiation of NT2/D1 cells was
induced by seeding 106 cells per 75-cmz flask in medium containing 10-x' M all-trans-RA
(Eastman Kodak Chemical Co., Rochester, NY) as previously described (4). MRC-5 (12)
and WI38 (13) diploid human fibroblasts were obtained from the Medical Research Council
(United Kingdom) and from Dr. Paul Phillips, the Wistar Institute, respectively.
Virus.
￿
The Towne strain of HCMV was plaque purified and propagated on MRC-5 cells
as previously described (14). The infectivity of the stock virus, assayed by the virus plaque
method (15), was 1 x 106 to 3 x 106 PFU/ml. In additional experiments, we also used the
established laboratory HCMV strain Ad-169 (16), obtained from the American Type Culture
Collection (Rockville, MD), the low-passage strain Toledo (17), and a fresh isolate provided
by the Clinical Virology Laboratory, Children's Hospital of Philadelphia.
Immunoassays of Cell Surface and ViralAntigens.
￿
mAbs MC480 (anti-SSEA-1) (18) and A2B5
(19) were used to detect expression of their corresponding cell surface glycolipid antigens,
using either immunofluorescence or radioimmunobinding assays as previously described (3,
20), or immunoTLC (thin-layer chromatography) analysis (see below). SSEA-1 is a lacto-
series glycolipid antigen and its epitope has been identified with the Lex structure (21, 22);
Lex expression was also assayed using mAbs PM 81 (23) and D, 56-22 (24). A2B5 recog-
nizes a ganglioside, GT,3 , in NT2/Dl cells (10). mAb A5 (25), recognizing unsubstituted lac-
toseries core glycolipids, was also used in immunoTLC analysis.
Viral antigens were detected using a pool offourhuman convalescent sera (Clinical Virology
Laboratory, Children's Hospital of Philadelphia) at a dilution of 1 :15. In separate tests, we
confirmed that this serum pool detected immediate early (IE), early (E), and late (L) HCMV
antigens, but did not react with uninfected, SSEA-1' cells.
The coexpression of cell surface and viral antigens was assayed by a two-color immunofluores-
cence technique (10), modified as follows. As previously described for flow cytofluorometric
analysis (3, 20), cells were reacted in suspension with a murine mAb to the surface antigen
followed by rhodamine-conjugated goat anti-mouse Ig antibodies that had been preabsorbed
to remove crossreactivity to human Ig (Cappel Laboratories, Malvern, PA). The cells were
then cytocentrifuged onto slides, air dried, and fixed with acetone, after which they were
sequentially reacted with anti-HCMV sera and fluorescein-conjugated goat anti-human Ig
that had been preabsorbed to remove crossreactivity to mouse Ig. In each experiment, con-
trols were included to confirm the specificity of the reagents and their lack of crossreactivity.
Glycolipids.)
￿
Glycolipids were extracted from pellets of HCMV and cultured cells using
isopropyl alcohol/hexane/water (55:25 :20). For cultured cells, total lipid extracts were parti-
tioned into an upper and a lower phase according to the method of Folch-Pi (27). The Folch-
Pi upper phase was chromatographed on DEAE-Sephadex in order to separate neutral and
acidic fractions (28). Neutral glycolipids were eluted with methanol, while acidic glycolipids
(gangliosides) were eluted with chloroform/methanol/water (30:60:8) containing 0.8 M so-
dium acetate. TLC immunostaining was performed as described previously (10), except that
TLC plates were dipped in 0.05% polyisobutyl methacrylate (Aldrich Chemical Co., Mil-
waukee, WI) in diethyl-ether prior to antibody staining.
z Glycolipids are designated according to the recommendations of the IUPAC Nomenclature Com-
mittee, but the suffix OseCer is omitted (26).ANDREWS ET AL.
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Enzyme Assays.
￿
Tissue culture cells were homogenized in 2 vol of a buffer composed of
50 mM Hepes buffer, pH 7.2, 0.5 M sucrose, 1 mM EDTA by two strokes ofPotter-Elvehjem
homogenizer and used as enzyme source in the following assays.
/31-3N-acetylglucosaminyltransferase was assayed as previously described (29) in reac-
tion mixtures containing 2.5 Amol of Hepes buffer, pH 7.2, 40 tug of lactosylceramide, 150
tag of Triton CF54, 0.5 jmol of MnC12, 0.5 lmol of CDPcholine, 50 nmol of UDP['4C]N-
acetylglucosamine (9,000 cpm/nmol), and 375-425 p.g of protein in a total volume of 0.05
ml. The reaction mixture was incubated for 2 h at 37'C and terminated by addition of 50
1Al of 0.25M EDTA and 0.6 ml chloroform/methanol (2:1). The entire reaction mixture was
streaked onto a 4-cm wide strip of Whatman 3 paper and chromatographed with water over-
night. The glycolipid remaining at the origin was extracted with 2-5-ml washes of chloro-
form/methanol/water (10:5:1). The solvent was removed with a nitrogen stream and dissolved
on 20 til chloroform/methanol (2 :1). A 10-I .1 aliquot was removed and spotted onto a high-
performance TLC (HPTLC) plate (Merck, Darmstadt, FRG) and developed in a solvent
of chloroform/methanol/water (60:40:9) containing 0 .02% CaC12-2H20 as a final concen-
tration. Standard glycolipids were visualized by orcinol spray. Radioactive glycolipid bands
were located by autoradiography, scraped from the plate, and counted by a liquid scintilla-
tion counter. 1 U of activity is defined as transfer of 1 pmol ofN-acetylglucosamine per hour
under the conditions of the assay.
This methodology was also followed for assays ofX31-4galactosyltransferase and a1-3fu-
cosyltransferase activities using the conditions described by Holmes et al. (30). In addition,
al -4galactosyltransferase activity with lactosylceramide as the acceptor was determinedunder
conditions defined by Wiels et al. (31). a-Fucosidase activitieswere determined as described
by Barlow et al. (32).
Protein Determination.
￿
Protein concentrations ofcell fractions were determined by the method
of Lowry et al. (33) using BSA as the standard.
Results
SurfaceAntigen Expression in HCMV-infected Teratocarcinoma CellsandFibroblasts.
￿
Since
HCMV replication occurs in only a subset of differentiated NT2/D1 cells, we used
two-color immunofluorescence to determine whether the HCMVpermissive cells
are characterized by a particular pattern of surface antigen expression (Table I).
Cultures of NT2/D1 cells that had been exposed to 10-5 M RA for 7 d were reseeded
in the absence of RA and infected with HCMV; the expression of viral antigens
and cell surface differentiation antigens was assayed 6 d later. Ofthe cells replicating
HCMV and expressing HCMVspecific antigens, 69% were also SSEA-l' ; con-
versely, 72% of the SSEA-1' cells were HCMV' . Very few SSEA-1' cells were evi-
dent in the uninfected control cultures, suggesting that infection with HCMV in-
duces expression of this antigen. By contrast, very few HCMV+ cells expressed the
ganglioseries antigen AM, which is commonly expressed by many differentiated
NT2/Dl cells (10).
Notwithstanding the present results, in other experiments SSEA-1 is commonly
expressed by some uninfected, differentiated NT2/Dl cells; typically, a peak of ex-
pression by ti20% of the cells after 7 d of RA exposure is followed by disappearance
of the antigen, so that very few SSEA-1' cells are ordinarily found after a further
7 d (10). Thus, rather than inducing SSEA-1, HCMV might preferentially infect
SSEA-1' cells and stabilize expression of this antigen. However, after isolating
SSEA-1' and SSEA-1 - subsets of differentiated NT2/Dl cells by FAGS and testing
their relative susceptibilities to HCMV infection, we did not detect any differences
that would support this notion (data not shown). Unfortunately, the variability in
SSEA-1 expression by uninfected NT2/Dl cells, as well as the heterogeneity ofthese1350
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Ocultures and absence ofHCMV permissiveness in all ofthe cells, posed difficulties
foradetailed investigation oftherelationship between HCMV infection andSSEA-1
expression in the teratocarcinoma system. We therefore investigated the expression
ofSSEA-1 indiploid human fibroblasts, which are fully permissive for HCMV repli-
cation.
Infection ofMRC-5 orW138 fibroblasts with HCMV also ledto amarked induc-
tion of SSEA-1 expression, whereas SSEA-1 was not expressed by the uninfected
cells at any stage of their growth cycle (Fig. 1). SSEA-1 was first detectable N3 d
after infection, when cytopathic effects were already evident in some cells, and its
expression increased up to 6 d after infection, by which time almost all the cells ex-
pressed a cytopathic effect. The SSEA-1 epitope has been identified as the fucose
cd-3G1cNAc structure carried on the type 2 polylactosamine chains oflactoseries
glycolipids, a carbohydrate structure also known as Le" (1113 FucnLC4) (21, 22). Ac-
cordingly, similar resultswere obtained withmonoclonal anti-SSEA-1 and two other
monoclonal anti-Le" antibodies, PM81 and Dt-56-22 (23, 24) (Fig. 1). As with the
differentiated NT2/D1 cells, only one-third toone-halfofthe HCMVinfectedfibro-
blasts expressed SSEA-1 (Table 11). In addition to the Towne strain ofHCMV, this
induction ofSSEA-1 was also observed (data not shown) upon infection with other
strains, includinganother establishedlaboratory strain (Ad-169), alow-passage strain
(Toledo), and a strain freshly isolated in our laboratory. On the other hand, no in-
duction was observed after infection with HSV1 (data not shown).
HCMV-induced Changes in Membrane Glycolipids.
￿
Inparallel with the cell surface antigen
changes, glycolipid changeswere also detectable in HCMVinfected MRC-5 fibroblasts:
a series ofextended lactoseries glycolipids bearing the terminal SSEA-1 (Le") epitope
were identified in theneutral glycolipid fraction ofHCMVinfected but notuninfected
cells(Fig. 2). These glycolipids had the sameTLC mobility asmonofucosylated hepta-
3000
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FIGURE 1.
￿
Expression of the
Le' epitope in HCMVinfected
and uninfected MRC-5 and
W138 diploidhumanfibroblasts
determined by aradioimmuno-
binding assay using the three
mAbs anti-SSEA-1, PM81, and
D,56-22. Note that no SSEA-
1/Le"expression was detectable
in uninfected fibroblasts at any
stageof theirgrowth cycle;cells
in the left hand panel were
seeded 1 d before beginningthe
experiment, at a split ratio of
1:3, whereas cells to the right
hand panel were seeded 4-5 d
previously and were allowed to
grow to confluence before ini-
tiating theexperiment. In either
case Le" expression became de-
tectable only in theinfected cells
(moi = 0.1) beginning ti3 d
after infection.1352
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TABLE 11
Coexpression of SSEA-1 and Viral Antigens in MRC-5 Fibroblasts Infected with HCMV
Confluent cultures ofMRC-5 fibroblasts were infected with HCMV (moi = 0.1) on day
0 ; cells were harvested on day 3 and 6 after infection and assayed by two-color immunofluores-
cence for the coexpression of SSEA-1 and viral antigens .
' The numbers of cells counted are shown in parentheses .
Estimates based on scanning several fields of cells without counting .
S NC, not counted .
saccharide (V'FucnLc6, Y2), difucosylated heptasaccharide (VIII1FucnLc6, diy2),
monofucosylated nonasaccharide (VII'FucnLc8, Zt), and difucosylated nonasaccha-
ride (VII'VFucnLc8, Z2), respectively (22) . A series of extended lactoseries glyco-
lipids bearing the terminal Ley epitope (Fucal-2Ga1M-->4[Fuca1-3]-G1cNAc) were
also detected, and parallel immunofluorescence experiments confirmed cell surface
binding of anti-Ley mAb (data not shown) . Glycolipids with Lex and Ley structure
were not detected in extracts ofHCMV itself, confirming that their appearance in
MRC-5 cells was not due to passive transfer during viral infection .
An increase in unsubstituted lactoseries core glycolipids nLe6 and nLc8 was also
observed in the upper-phase neutral glycolipid fraction ofHCMVinfected MRC-5
cells usingmAbA5 (25) . However, lactoseries glycolipids Le', Ley, nLe6, and nLc8
were not detected by orcinol spray, suggesting that they are relatively minor mem-
FIGURE 2 .
￿
TLC immunostaining analysis of lactoseries glycolipid changes in HCMVinfected
MRC-5 cells, 6 d after infection (see Fig . 1) . Folch-Pi lower-phase (LP, upper-phase neutral
(UN), and upper-phase gangliosidic (UG) glycolipids were obtained from noninfected (N) and
HCMVinfected (moi = 0 .1) (I) MRC-5 cells. Each lane represents the glycolipid equivalent
of -2 x 10' cells. Glycolipids isolated from purified HCMV virions (V) (30 Wg viral protein)
are also shown . In addition, upper-phase neutral glycolipids obtained from a human tumor sample
(T) are included on the left as a positive control. Replicate plates were developed using a solvent
system of chloroform/methanol/water (50:55:18) and either stained for carbohydrate by the or-
cinol sulfuric acid reaction (orcinol) or labeled with mAbs anti-SSEA-1 or A5 .
Days after infection
HCMV'
% of Total
cells'
% of SSEA-1*
SSEA-1'
% of Total %
cells'
of HCMV'
3d
Noninfected 0 (0/1,000) - 2 (14/521) -
Infected 29 (57/194) 90(90/100) 8 (14/175) 41 (36/88)
6d
Noninfected 0 (0/1,000) - 0(0/1,000) -
Infected 951 1001 23 (54/237) NCSANDREWS ET AL.
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brane components. Bycontrast to the general increase inlactoseries glycolipids after
HCMV infection, the expression of globoseries glycolipids was not significantly
changed after infection (not shown). Thus, HCMV infection appears to be accom-
panied by a specific increase in lactoseries glycolipid biosynthesis.
Glycosyltransferase Activities in Infected and Noninfected Fibroblasts.
￿
The appearance
ofSSEA-1 in HCMVinfected cells suggests that viral infection may trigger an in-
crease in the activity of key glycosyltansferases. Indeed, after HCMV infection of
MRC-5 cells, the specific activities of ail-4galactosyltransferase and al-3fuco-
syltransferase increased two- and threefold, respectively, while X31--"3N-acetylglu-
cosaminyltransferase, associated with synthesis of LC from lactosylceramide, the
first step in lactoseriescore chain synthesis, was undetectable in the uninfected cells
but detectable at a low activity (N5 pmol/h/mgprotein) in the HCMVinfected cells
(Table III, Fig. 3). The relative specific activities ofthese enzymes suggest that for-
mation of Lc3 is the rate-limiting step in synthesis ofSSEA-1 active carbohydrate
structures, and that the appearance ofalow activity of01-3N-acetylglucosaminyl-
transferase is most probably chiefly responsible for the marked effect of HCMV in-
fection on the cell surface expression oflactoseries carbohydrate epitopes. An iden-
tical mechanism has been found to be responsible for the accumulation of large
quantities of lactoseries antigens during oncogenesis in human colon (30).
A generalized activation ofenzymes associated with oligosaccharide biosynthesis
and degradation occurring asa consequence ofHCMV infectionwas suggested since
TABLE III
Glycosyl Transferase Activity in MRC-5 before and after HCMV Infection
Confluent cultures of MRC-5 fibroblasts were infected, or mock infected, with HCMV (moi = 0.1) and
harvested after 6 d, when cell lysates were prepared and enzyme activities determined. The fucosyltransfer-
ase activity was cil-3 specific, as no transfer into Lc4 was detected. In the assay for 51-4 galactosyltrans-
ferase no synthesis ofan Lc4, type 1 chain paragloboside product was detected, indicating no type 1 chain
lactoseries synthesis in either infected or uninfected cells . The /3(l-3)N-acetyl-glucosaminyl transferase yield-
ed a product as shown in Fig. 3 based on autoradiography or reaction products after separation by TLC.
A detectable band was found for the infected cells (lane 4), whereas no significant spot was found for the
uninfected cells (lane 3).
Enzymes
HCMV
infection Specific activity
pmotlhlmg protein
Lactoseries enzymes
al-3fucosyltransferase - 101 t 8
+ 286 t 18
01-4galactosyltransferase - 2,340 t 28
+ 4,340 t 34
51-+3N-acetylglucosaminyl transferase - ND
+ 5 (see Fig. 3)
Other enzymes
al -4galactosyltransferase - 34.3
+ 55.9
a-fucosidase - 0.32 (mmol/h/mg protein)
+ 0.66 (mmol/h/mg protein)1354
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FIGURE 3.
￿
TLC analysis of /31-"3N-acetylglucosaminyltransferase
reaction products from homogenates of uninfected and HCMV
infected (moi = 0.1) MRC-5 cells . (Lane 1) Standard lactosylcera-
mide ; (lane 2) standard Lct ; (lane 3) autoradiograph ofproduct from
incorporation of "C-N-acetylglucosamine into lactosylceramide cata-
lyzed by lysates of uninfected cells ; (lane 4) autoradiograph ofproduct
from incorporation of "C-N-acetylglucosamine into lactosylceramide
catalyzed by lysates of HCMVinfected cells. No labeled productwas
detected when the exogenous lactosyl ceramide acceptor wasomitted
(not shown) . Cell lysates were prepared and the /31-+3N-acetyl-
glucosaminyltransferase activity determined as previously described
(29) . The platewas developed in a solvent ofCHCI3/CH,;OH/H20
(60:40 :9) containing 0.02% CaC12-2Hz0 as a final concentration .
Standard glycolipids were visualized by orcinol spray.
a1-4galactosyltransferase, responsible for the biosynthesis of Gb3 by transfer of
galactose to lactosylceramide, as well as thehydrolytic enzyme a-fucosidase, increased
about twofold upon infection (Table III) .
Discussion
In cultures of differentiating teratocarcinoma cells, and of diploid human fibro-
blasts, many cells infected with HCMV expressed the cell surface antigen SSEA-1,
an epitope identified with the Le" hapten, fucose(a1-3)G1cNAc (21, 22) . TLC anal-
ysis ofneutral glycolipids from infectedand noninfected fibroblastsconfirmed amarked
increased in the SSEA-1 (Le")-reactive glycolipids of the infected cells . This change
in cell surface glycolipid antigen expression resulting from infection appears to be
due to subtle alterations in the relative competition for common precursor struc-
tures at key points in the biosynthetic pathways, rather than activation ofa single
glycosyltransferase . In particular, the results suggested that alterations in J31-3N-
acetylglucosaminyltransferase activity after infection cause slightly increased syn-
thesis of Lc3 which is rapidly converted to SSEA-1 (Le")-reactive products . How-
ever, the increased activities of other enzymes, such as al-3fucosyltransferase, may
also contribute to the final result . It should be noted that, 6 d after infection, only
about one-third of the fibroblasts expressed surface-detectable SSEA-1, whereas all
the cells were replicating virus ; we do not currently understand the basis for such
SSEA-1 + and SSEA-1" subsets of infected cells and do not know whether greater
increases in the activities of the glycosyltransferases occur in the SSEA-l + cells .
Changes in carbohydrate antigen expression have also been reported after infec-
tion of cells with other viruses . For example, the lactoseries glycolipid Ley was re-
cently found to be induced in humanT cell lines after HIV infection (34) . Also,
transfection of rat cells with the transforming gene ofhuman adenovirus type 12
induced the synthesis of the disialoganglioside GD3, which was subsequently shownANDREWS ET AL.
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to result from activation of a highly specific sialyltransferase, GD3 synthetase (35,
36). However, in the present case, infection seems to have pleiotropic effects on car-
bohydrate synthetic enzymes. Indeed, HCMV has been reported to influence ex-
pression of a large number of other host enzymes. Examples of the enzymes and
other proteins induced after HCMV infection include poly-ADP ribose synthetase
(37), RNApolymerase (38), thymidine-kinase (39, 40), ornithinedecarboxylase(41),
plasminogen activator(42), DNA-poly-merase a (43), bovine growth hormone(44),
an inhibitor of IL-1 (45), and a factor that is released into the culture medium and
stimulates cellular DNA synthesis (46).
Generally, stimulation of host cell enzymes and production of DNA-binding pro-
teins in HCMVinfected cellsprecedes viral DNA synthesis; recently the product(s)
of the IE2 region has been described as a potent and nonspecific transactivator of
heterologous virus and cellular target promoters (47-49). However, thetime ofSSEA-1
appearance after HCMV infection suggests that its induction may be a late viral
function, although we cannot yet exclude the possibility that it is a delayed conse-
quence of IE gene activity.
During embryogenesis in the mouse, SSEA-1 first appears during late cleavage
stages; it is subsequently expressed on the primitive ectoderm and, during later stages
ofdevelopment, on various tissues includingparts ofthe nervous system (18, 50-52).
Several studies have indicated that carbohydrates bearing the SSEA-1 epitope may
play arole in mediatingor directing some critical cell-cell interactions during devel-
opment. For example, carbohydrates bearing multivalent Le" structures have been
reported to block compaction of the morula during early mouse development (53,
54). Other studies have suggested that lactoseries carbohydrates and complemen-
tary lectins act as recognition signals that guide the formation of correct neuronal
interconnections in parts of the developing rat peripheral nervous system (55-57).
Consequently, the observations reported here raise the question of what effects the
induction of the lactoseries carbohydrate antigens, such as SSEA-1, may have on
the developing fetus if that inductionwere to occurat an inappropriate time or place.
Although the deleterious effects of HCMV infection on the developing fetus might
be due to the infection and subsequent death of specific critical cell types, there is
no direct evidence for or against such ahypothesis. In view of the ability of HCMV
to cause multiple physiological changes in infected cells, as well as its propensity
for latent infection, alternative possibilities should also be entertained. It is notable
that damage to the central nervous system is a prominent consequence of HCMV
infection in utero, while lactoseries carbohydrates, among others, have been pro-
posed to have a role in guiding some neuronal interactions.
Summary
Cell surface expression of stage specific embryonic antigen 1 (SSEA-1), or Le"
(III3 FucnLC4), was induced in differentiated human teratocarcinoma cells and in
humandiploidfibroblasts 3-6 dafterinfectionwith human cytomegalovirus (HCMV).
In parallel, fucosylated lactoseries glycolipids bearing the SSEA-1/Le" epitope were
readily detected in the infected cells but not in the uninfected cells. HCMV infec-
tion also results in altered expression of several glycosyltransferases. SSEA-1/Le"
induction is probably a consequence of both increased expression of 01-3N-
acetylglucosaminyltransferase, which catalyzes the rate-limiting step in lactoseries1356
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core chain synthesis, and subtle alterations in the relative competition for common
precursor structures at key points in the biosynthetic pathway. Since SSEA-1 has
been suggested to play a role in some morphogenetic cell-cell interactions during
embryonic development, the induction ofthis antigen at inappropriate times might
provide one mechanism whereby intrauterine infection with HCMV can damage
the developing fetal nervous system.
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